Questionable Industry-Sponsored Postneonatal Pediatric Studies in Slovenia

ConclusionsPediatric studies triggered by US and EU regulatory demands are a serious abuse of nonneonatal children and adolescents in Slovenia and worldwide. They are medically redundant at best and often deter patients from effective innovative personalized therapy. They also exclude young patients from reasonable studies. Institutional review boards/ethics committees should be alerted, should critically review all ongoing pediatric studies, should suspend those found to be questionable, and should reject newly submitted questionable ones.
Source: Current Therapeutic Research - Category: Drugs & Pharmacology Source Type: research